Navigation Links
Relocatable Non-Invasive Frame (for fractionation)

ProductsRelocatable Non-Invasive Frame (for fractionation)
Company 3D Line USA Inc.
Item Relocatable Non-Invasive Frame (for fractionation)
Features This frame is completely compatible with our head ring holder and multimodality localizer that can be shared between the single-dose and non-invasive frames. The casting procedure takes about 10/12 minutes. The reproducibility of the relocatable system has been improved by the usage of an high technology hydraulic arms fixation system, coming from the Headfix system, developed and manufactured by Medical Intelligence. The Headfix system, by means of a vacuum pump, provides accurate and safe reproducibility of the patient.
Description Relocatable frame has been designed specifically for fractionated stereotactic radiotherapy treatments. It provides a fast, non-invasive and reproducible fixation of the patient.
Info 3D Line USA Inc.
Customer Service: (703) 467-8420
Web site: http://www.3dline.com/

Related medicine products :

1. Stereotactic Relocatable Frame (Non-Invasive Frame)
2. Guhl Non-Invasive Ankle Distractor System
3. Adult Trial Frame
4. Half Eye Trial Frame - Adult
5. Half Eye Trial Frame - Child
6. Classic Trial Frames UB3
7. Universal Trial Frames UB4
8. Childrens Half Trial Frames
9. Half Trial Frames
10. Grafton Trial Frame
11. Adjustable Trial Frame - Adult
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products:
(Date:1/19/2017)... Texas (PRWEB) , ... January 19, 2017 , ... Students ... GenCure Tissue Donation Awareness Scholarship competition., The winner will earn a $1,000 scholarship and ... The competition begins Feb. 1, and the deadline is May 31, with the winner ...
(Date:1/19/2017)... Pittsburgh, PA (PRWEB) , ... January 19, 2017 , ... ... the experience of patients who seek access to the Network’s programs and services in ... requesting primary or specialty care appointments will be offered one for that same afternoon. ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the third ... New Jersey and the surrounding area, is inaugurating a charity event to ... commonly known as Lou Gehrig's disease or motor neurone disease, is a deadly ...
(Date:1/19/2017)... CT (PRWEB) , ... January 19, 2017 , ... ... certified Reproductive Endocrinologists at Reproductive Medicine Associates of Connecticut (RMACT) have earned ... Dr. Cynthia Murdock and Dr. Shaun Williams have each been chosen by their ...
(Date:1/19/2017)... VA (PRWEB) , ... January 19, 2017 , ... The ... Thrive in 2017, **An FDAnews Webinar**, Jan. 26, 2016 — 1:30 p.m. – 3:00 ... about the 21st Century Cures Act in order to thrive this year? , The ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Jan. 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ... mitochondrial dysfunction, today announced new additions to its senior ... Chief Medical Officer, and Daniel Geffken as ... Jim Carr , Pharm.D. has been promoted to ... pleased to welcome Doug and Daniel to our management ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017  Abaxis, Inc. ... manufacturing point-of-care blood analysis instruments and consumables for the ... call to discuss its financial results for the third ... call will be at 4:15 p.m. ET on Thursday, ... for the third quarter fiscal year 2017 after the ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
Breaking Medicine Technology: